Literature DB >> 2683039

Strategies for linkage studies of schizophrenia: pedigrees, DNA markers, and statistical analyses.

S R Diehl1, K S Kendler.   

Abstract

A current overview of the genetics of schizophrenia is presented. Recently reported linkage studies of schizophrenia using polymorphic DNA markers are discussed and critically evaluated. Linkage studies of schizophrenia that we are currently undertaking are described, and the rationale underlying the specific strategies that we are using is explained. Our major focus is on extended pedigrees ascertained in Ireland containing a high density of schizophrenic cases, but we are also planning to use the technique of homozygosity mapping in an attempt to localize a recessively inherited gene that may be segregating in consanguineous families ascertained in Saudi Arabia. Issues relating to diagnostic criteria, the choice of which DNA markers to type with the highest priority, and appropriate statistical methodology are also considered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683039     DOI: 10.1093/schbul/15.3.403

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  4 in total

1.  Evidence of linkage disequilibrium between schizophrenia and the SCa1 CAG repeat on chromosome 6p23.

Authors:  S Wang; S D Detera-Wadleigh; H Coon; C E Sun; L R Goldin; D L Duffy; W F Byerley; E S Gershon; S R Diehl
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

2.  Joint linkage of multiple loci for a complex disorder.

Authors:  C J MacLean; P C Sham; K S Kendler
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

Review 3.  Chromosomal aberrations and schizophrenia. Autosomes.

Authors:  A S Bassett
Journal:  Br J Psychiatry       Date:  1992-09       Impact factor: 9.319

Review 4.  Identification of the phenotype in psychiatric genetics.

Authors:  M T Tsuang; S V Faraone; M J Lyons
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.